Career Center




BioScience Forum | "Translating Molecular Virology into Novel Therapies for Hepatitis" with Jeffrey Glenn, MD, PhD

Date:   Wednesday, November 17, 2010
Time:   6:00-9:00pm

The Clarion Hotel
401 East Millbrae Ave.
Millbrae, CA



Sponsor:   BioScience Forum
Event details:  

Hepatitis viruses are important causes of world wide liver disease. Hepatitis C virus (HCV) infects over 150 million people and is the number one cause of liver transplantation and liver cancer in the United States. Unfortunately, our current therapies are inadequate for most patients. Hepatitis delta virus (HDV) causes the worst form of human hepatitis and there is no effective therapy. The study of the molecular virology of these viruses, however, has revealed new targets that can form the basis of novel therapies. Examples of such "bench-to-bedside" efforts will be presented. If successful, they could change the paradigm for how we treat these challenging infectious diseases.

Jeffrey Glenn is an Associate Professor of Medicine in the Division of Gastroenterology and Hepatology at Stanford University School of Medicine, and the Director of the Center for Hepatitis and Liver Tissue Engineering. He also heads a research laboratory focused on studying molecular virology and the translation of that knowledge into novel antiviral strategies, as well as the development of new models with which to study hepatitis viruses and liver diseases. He is also the founder of Eiger BioPharmaceuticals, Inc., a local biotechnology company developing several new classes of antiviral drugs.
Glenn was born in Los Angeles, and grew up in Switzerland. He received his B.A. degree in Biochemistry and French Civilization from U.C. Berkeley from where he graduated summa cum laude. He received his M.D. and Ph.D. in Biochemistry and Biophysics from U.C.S.F. He trained in internal medicine at Stanford University where he completed specialty training in gastroenterology, and joined the faculty in 2000.
He is the principal investigator on multiple NIH grants, a member of the Viral Hepatitis Working Group for NIH Action Plan for Liver Disease Research, has served on multiple NIH Study Sections, and is the inventor on numerous patents. He is also the recipient of a Burroughs Wellcome Fund Career Award, a Burroughs Wellcome Fund Clinical Scientist Award in Translational Research, the American Gastroenterological Association Young Investigator Basic Research Award, and an elected member of the American Society for Clinical Investigation.



Fee:   Sliding scale $35-45 for pre-registration, plus $3 service fee
Additional information and/or registration:  

Registration: Please pre-register at BioScience Forum

Footer Links: